![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 28, 2014 10:21:28 AM
I don't think the shorts or the flipper can depend on buying any substantial number of shares below .08 as there are numerous current "longs" waiting to add shares should it go below .08. Lots of competition there.
Obviously the next "expected" catalyst will be the LymPro data and a subsequent partnership announcement. It is often said in marketing to "sell the sizzle and not the steak". I'm expecting the share price to move to the .20-.25 range with a partnership in place however I think with the right media campaign to promote LymPro that the "hype" could take the share price much higher on a temporary basis. Anyone who has followed "penny stocks" knows that having a "hot item" to promote such as blood test to detect Alzheimer's could generate substantial attention to the stock and the share price could hit the .50 range. In any event the next six weeks will be very interesting as will the months to follow.
Twitter: @AmarantusBio .... 9,971 followers.
FEATURED POET Technologies Reports Second Quarter 2024 Financial Results • Aug 15, 2024 8:04 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
ATWEC Reaches Profitability, Announces Massive Earnings Growth, and a Strong Forecast for the Rest of 2024 • ATWT • Aug 15, 2024 7:16 AM